A 1-Year Study of an Investigational Drug in Obese Patients (0557-012)(COMPLETED)

A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety, Tolerability, and Efficacy of MK0557 in Obese Patients

This is a 1-year study to assess the safety, tolerability, and efficacy of an investigational drug in obese patients after a very low calorie diet.

Inclusion Criteria:

• Obese men and nonpregnant women between the ages of 18 and 65 years with a body mass index (height to weight ratio) as required by the study.

Exclusion Criteria:

• Patients with uncontrolled high blood pressure and/or diabetes mellitus (high blood sugar)